A retrospective study of the safety and efficacy of low molecular weight iron dextran for children with iron deficiency anemia.

Alexander A BoucherAshley BedelSommer JonesStephanie F LenahanRebecca GeerPatrick T McGann

Published in: Pediatric blood & cancer (2021)

In a large institutional cohort, LMWID was well tolerated in children and adolescents, with most patients having their total iron deficits relieved in a single infusion. These data support expanded use of LMWID in the management of pediatric iron deficiency.

Keyphrases

iron deficiency
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
young adults
traumatic brain injury
low dose
machine learning
artificial intelligence